# A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis

> **NCT01667094** · PHASE4 · UNKNOWN · sponsor: **The Alfred** · enrollment: 50 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Intermittent, short infusion Ceftazidime
- **DRUG:** Continuous infusion Ceftazidime
- **DRUG:** Intermittent, short infusion Meropenem
- **DRUG:** Continuous infusion Meropenem
- **DRUG:** Intermittent, short infusion Ticarcillin-clavulanate
- **DRUG:** Continuous infusion Ticarcillin-clavulanate
- **DRUG:** Intermittent, short infusion Cefepime
- **DRUG:** Continuous infusion Cefepime
- **DRUG:** Continuous infusion Piperacillin tazobactam
- **DRUG:** Intermittent, short infusion Piperacillin tazobactam

## Key facts

- **NCT ID:** NCT01667094
- **Lead sponsor:** The Alfred
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01667094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01667094, "A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01667094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*